These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17045857)

  • 1. Malignant progression of a small HCC nodule: hypovascular 'early HCC' converted to hypervascular 'small HCC' within six months.
    Golfieri R; Coppola F; Fusco F; Li Bassi S; Caraceni P; Bernardi M; Trevisani F
    Dig Liver Dis; 2007 Sep; 39(9):883-90. PubMed ID: 17045857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase MR imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease.
    Jang KM; Kim SH; Kim YK; Choi D
    Acta Radiol; 2015 May; 56(5):526-35. PubMed ID: 24838304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of a hypovascular hepatic nodule showing hypointensity on hepatocyte-phase image is a risk factor for hypervascular hepatocellular carcinoma.
    Ichikawa S; Ichikawa T; Motosugi U; Sano K; Morisaka H; Enomoto N; Matsuda M; Fujii H; Araki T
    J Magn Reson Imaging; 2014 Feb; 39(2):293-7. PubMed ID: 23633285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small hepatocellular carcinomas in cirrhosis: differences in contrast enhancement effects between helical CT and MR imaging during multiphasic dynamic imaging.
    Hayashida M; Ito K; Fujita T; Shimizu A; Sasaki K; Tanabe M; Matsunaga N
    Magn Reson Imaging; 2008 Jan; 26(1):65-71. PubMed ID: 17566685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.
    Forner A; Vilana R; Ayuso C; Bianchi L; Solé M; Ayuso JR; Boix L; Sala M; Varela M; Llovet JM; Brú C; Bruix J
    Hepatology; 2008 Jan; 47(1):97-104. PubMed ID: 18069697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal lesions in the cirrhotic liver: their pivotal role in gadoxetic acid-enhanced MRI and recognition by the Western guidelines.
    Golfieri R; Garzillo G; Ascanio S; Renzulli M
    Dig Dis; 2014; 32(6):696-704. PubMed ID: 25376286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance and early diagnosis of hepatocellular carcinoma.
    Lencioni R
    Dig Liver Dis; 2010 Jul; 42 Suppl 3():S223-7. PubMed ID: 20547307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.
    Yoo HJ; Lee JM; Lee JY; Kim SH; Kim SJ; Han JK; Choi BI
    Invest Radiol; 2009 Dec; 44(12):800-7. PubMed ID: 19838119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategy for hepatic hyperplastic nodules in heavy drinkers.
    Suzuki M; Maeyama S; Takahashi H; Okuse N; Takahashi Y; Mizuno H; Yotuyanagi H; Suzuki H; Itoh F; Uchikoshi T
    Alcohol Clin Exp Res; 2004 Aug; 28(8 Suppl Proceedings):153S-158S. PubMed ID: 15318104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranodular signal intensity analysis of hypovascular high-risk borderline lesions of HCC that illustrate multi-step hepatocarcinogenesis within the nodule on Gd-EOB-DTPA-enhanced MRI.
    Kobayashi S; Matsui O; Gabata T; Koda W; Minami T; Ryu Y; Kozaka K; Kitao A
    Eur J Radiol; 2012 Dec; 81(12):3839-45. PubMed ID: 22884705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatobiliary MR contrast agents in hypovascular hepatocellular carcinoma.
    Motosugi U; Bannas P; Sano K; Reeder SB
    J Magn Reson Imaging; 2015 Feb; 41(2):251-65. PubMed ID: 25104398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mysterious case of spontaneous disappearance of hepatocellular carcinoma.
    Del Poggio P; Mattiello M; Gilardoni L; Jamoletti C; Colombo S; Zabbialini G
    Dig Liver Dis; 2009 Jul; 41(7):e21-5. PubMed ID: 18420472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma.
    Bolondi L; Gaiani S; Celli N; Golfieri R; Grigioni WF; Leoni S; Venturi AM; Piscaglia F
    Hepatology; 2005 Jul; 42(1):27-34. PubMed ID: 15954118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidetector row CT and MR imaging in diagnosing hepatocellular carcinoma.
    Murakami T; Hori M; Kim T; Kawata S; Abe H; Nakamura H
    Intervirology; 2004; 47(3-5):209-26. PubMed ID: 15383731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of contrast-enhanced ultrasonography with dynamic flow imaging to evaluate therapeutic effects for hepatocellular carcinoma.
    Hotta N; Tagaya T; Maeno T; Ishikawa T; Okumura A; Fukuzawa Y; Kakumu S
    Hepatogastroenterology; 2003; 50(54):1867-71. PubMed ID: 14696421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of optimal timing of arterial phase imaging for the detection of hypervascular hepatocellular carcinoma by using triple arterial phase imaging with multidetector-row helical computed tomography.
    Murakami T; Kim T; Kawata S; Kanematsu M; Federle MP; Hori M; Okada A; Kumano S; Sugihara E; Tomoda K; Nakamura H
    Invest Radiol; 2003 Aug; 38(8):497-503. PubMed ID: 12874516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma.
    Manini MA; Sangiovanni A; Fornari F; Piscaglia F; Biolato M; Fanigliulo L; Ravaldi E; Grieco A; Colombo M;
    J Hepatol; 2014 May; 60(5):995-1001. PubMed ID: 24462368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypervascular hepatocellular carcinoma 1 cm or smaller in patients with chronic liver disease: characterization with gadoxetic acid-enhanced MRI that includes diffusion-weighted imaging.
    Kim JE; Kim SH; Lee SJ; Rhim H
    AJR Am J Roentgenol; 2011 Jun; 196(6):W758-65. PubMed ID: 21606265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma.
    Lencioni R; Piscaglia F; Bolondi L
    J Hepatol; 2008 May; 48(5):848-57. PubMed ID: 18328590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (<= 2.0 cm) in patients with hepatitis-induced liver cirrhosis.
    Park MJ; Kim YK; Lee MH; Lee JH
    Acta Radiol; 2013 Mar; 54(2):127-36. PubMed ID: 23148300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.